Bloomberg Intelligence sifted through thousands of listed firms and distilled a list of ten that merit close monitoring in Q2 2026. The slate spans semiconductors, banking, medical devices, gambling, luxury autos and exchange operators, featuring Broadcom, Deutsche Bank, Dexcom, DraftKings, Ferrari, Haleon, Japan Exchange Group, Magellan and others. Each company carries a specific catalyst that could move its stock sharply.

Broadcom’s AI accelerators, priced below Nvidia and AMD, could lift sales 69% to $113 billion by 2026, with June results set to confirm surge. Deutsche Bank aims for a 5% revenue rise to $38 billion as Germany’s infrastructure push fuels demand. Ferrari’s F80 and Luce have sold out through 2027, supporting an 8% sales gain. Dexcom will launch a 15‑day glucose monitor, targeting a 12% margin boost.

DraftKings expects 10% revenue growth as its sports‑betting base outpaces a new prediction‑market app, while Haleon eyes at least 10% profit expansion from U.S. analgesic and vitamin share gains. Japan Exchange Group could see a 27% sales jump as higher interest rates lift cash‑balance fees, and Magellan’s pending Barrenjoey purchase should add $35 billion AUM, nudging dividend yields. Together these catalysts offer investors upside across sectors.